Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 101–200 of 1,005
Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review
Almigbal, T. H., Alzarah, S. A., Aljanoubi, F. A., Alhafez, N. A., Aldawsari, M. R., Alghadeer, Z. Y., & Alrasheed, A. A. (2023) · Medicina · doi:10.3390/medicina59010182 · Cited by 79
“, hypertension, gestational diabetes, and preterm birth) [6].”
Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
Duan, L., An, X., Zhang, Y., Jin, D., Zhao, S., Zhou, R., Duan, Y., Zhang, Y., Liu, X., & Lian, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112094 · Cited by 70
Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction
Benito‐Vicente, A., Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Uribe, K. B., & Martín, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.013 · Cited by 65
Self-citationRecent Applications of Melanin-like Nanoparticles as Antioxidant Agents
Mavridi‐Printezi, A., Menichetti, A., Mordini, D., Amorati, R., & Montalti, M. (2023) · Antioxidants · doi:10.3390/antiox12040863 · Cited by 66
“Deviation from this balance and an uncontrolled increase in the radical content is known as “Oxidative Stress”, and it is associated with severe pathologies such as cancer [12], SARS-CoV-2 infection [13], diabetes mellitus [14], skin injuries [15–17], and kidney [18], liver [19] cardiovascular [20] and neurodegenerati…”
BackgroundIntermittent Fasting: Potential Bridge of Obesity and Diabetes to Health?
Zang, B.-Y., He, L.-X., & Xue, L. (2022) · Nutrients · doi:10.3390/nu14050981 · Cited by 56
“Its pathogenesis is involved in defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin, which means that patients have to rely on external insulin [52].”
BackgroundMethodPraparatana, R., Maliyam, P., Barrows, L. R., & Puttarak, P. (2022) · Molecules · doi:10.3390/molecules27082393 · Cited by 74
“From all diabetes cases, type 2 diabetes mellitus (T2DM) is the most common type, accounting for around 90–95% [4].”
BackgroundType 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
Martínez-López, Y. E., Esquivel-Hernandez, D. A., Sánchez-Castañeda, J. P., Neri-Rosario, D., Guardado‐Mendoza, R., & Reséndis-Antonio, O. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111952 · Cited by 65
“Notably, dysbiosis of the gut microbiome accompanies the progression of IR in T2D and the development of microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (atherosclerosis) complications of diabetes.(2,3) This dysbiosis remodels the intestinal barrier and insulin signals through metabolites de…”
BackgroundMagnesium Deficiency and Cardiometabolic Disease
Fritzen, R., Davies, A., Veenhuizen, M., Campbell, M. D., Pitt, S. J., Ajjan, R., & Stewart, A. J. (2023) · Nutrients · doi:10.3390/nu15102355 · Cited by 82
“Once T2DM has developed, individuals require treatment to reduce their serum blood glucose levels, including lifestyle advice and medications [77].”
BackgroundThe Effect of Omega-3 Fatty Acids on Insulin Resistance
Sinha, S., Haque, M., Lugova, H., & Kumar, S. (2023) · Life · doi:10.3390/life13061322 · Cited by 74
“Studies showed that abnormalities in insulin generation and/or function lead to a deterioration of glycemic control and culminate in the development of T2DM, which tends to result in dyslipidemia [3].”
BackgroundHalabitska, I., Бабинец, Л. С., Oksenych, V., & Kamyshnyi, O. (2024) · Biomedicines · doi:10.3390/biomedicines12081630 · Cited by 60
“Type 2 diabetes mellitus (T2DM), a prevalent metabolic disorder, arises from two primary factors: impaired insulin secretion by pancreatic β -cells and the reduced responsiveness of insulin-sensitive tissues to insulin [5].”
BackgroundAlwadeai, K. S., & Alhammad, S. A. (2023) · Medicine · doi:10.1097/md.0000000000034021 · Cited by 70
“Type 2 diabetes mellitus (T2DM) is one of the world’s most prevalent chronic metabolic diseases with high blood glucose levels.[1,2] Adipokines have been linked in a recent study to the etiology of obesity and the elevated risk of several comorbidities, particularly T2DM.”
BackgroundLi, F., Zeng, K., & Ming, J. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2278169 · Cited by 64
“Table 4 provided examples of various SDF that attenuated T2DM by modulating gut microbiota through multiple mechanisms, and the prebiotic effect of SDF was summarized in Figure 8(a).”
InfluentialDailah, H. G. (2024) · Healthcare · doi:10.3390/healthcare12030352 · Cited by 120
“Diabetes mellitus (DM) is a chronic, metabolic disease caused by defects in insulin function, insulin discharge, or both, which eventually results in increased blood glucose levels [1].”
BackgroundMerabet, N., Lucassen, P. J., Crielaard, L., Stronks, K., Quax, R., Sloot, P. M. A., la Fleur, S. E., & Nicolaou, M. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100972 · Cited by 87
Insulin Resistance Is Cheerfully Hitched with Hypertension
Sinha, S., & Haque, M. (2022) · Life · doi:10.3390/life12040564 · Cited by 85
“Specifically, insulin-mediated nitric oxide production (NO) from vascular endothelium leads to increased blood flow, enhancing the removal process of glucose [89].”
BackgroundInverse Association between Oxidative Balance Score and Incident Type 2 Diabetes Mellitus
Kwon, Y., Park, H.-M., & Lee, J. (2023) · Nutrients · doi:10.3390/nu15112497 · Cited by 52
Kalinovskii, A. P., Sintsova, O. V., Gladkikh, I. N., & Leychenko, E. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216514 · Cited by 70
“Epidemiological studies suggest that many cases of T2D are mainly caused by manageable risk factors, i.e., obesity, low physical activity, and an unhealthy diet; however, genetic predisposition and environmental factors also contribute to the prevalence of diabetes [3].”
BackgroundSabiu, S., Balogun, F. O., & Amoo, S. O. (2021) · Molecules · doi:10.3390/molecules26164867 · Cited by 56
“Diabetes, one of the leading causes of death globally, is a chronic metabolic derangement leading to high levels of glucose in systemic circulation (hyperglycaemia) due to the inability of the body to manage available glucose levels, arising from ineffective or insensitive insulin secretion by islets of Langerhans bet…”
BackgroundTan, D., Tseng, H. H. L., Zhong, Z., Wang, S., Vong, C. T., & Wang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231910988 · Cited by 57
“T2 is ainly characterized by hyperglyce ia, hich eventually results in chronic i s li resista ce i insulin-sensitive tissues and defective insulin secretion by pancreatic β-cells [4].”
BackgroundGandhi, G. R., Hillary, V. E., Antony, P. J., Zhong, L. L. D., Yogesh, D., Krishnakumar, N. M., Ceasar, S. A., & Gan, R. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2170320 · Cited by 60
“Type 2 diabetes (T2DM) is a chronic metabolic syndrome induced through pancreatic β-cell dysfunction, and is featured with insulin resistance, hyperglycemia, and hyperlipidemia, in the target organs (Galicia-Garcia et al. 2020).”
BackgroundFuentes-Barría, H., Aguilera-Eguía, R. A., Flores-Fernández, C., Angarita, L., Rojas-Gómez, D. M., Alarcón-Rivera, M., López-Soto, O., & Maureira-Sánchez, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052153 · Cited by 245
“This leads to a silent progression that only manifests evident symptoms once significant organic damage has occurred [24–31].”
InfluentialEpigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus
Yang, Y., Luan, Y., Feng, Q., Chen, X., Qin, B., Ren, K., & Luan, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.807413 · Cited by 59
“Intuitively, T2DM is induced either by insulin resistance (IR) from insulin-responsive cells and tissues or pancreatic β-cell dysfunction, leading to inadequate secretion of insulin (Galicia-Garcia et al., 2020).”
BackgroundManickam, R., Tur, J., Badole, S. L., Chapalamadugu, K. C., Sinha, P., Wang, Z., Russ, D. W., Brotto, M., & Tipparaju, S. M. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12887 · Cited by 50
“maintaining glucose homeostasis, resulting in elevated blood glucose levels leading to hyperglycaemia.(2,3) The occurrence of type 2 diabetes has increased rapidly in the last few de-”
BackgroundWiniarska‐Mieczan, A., Tomaszewska, E., & Jachimowicz-Rogowska, K. (2021) · Nutrients · doi:10.3390/nu13113972 · Cited by 55
“90%) of all diabetes cases and is observed primarily in older patients whose blood shows no presence of the antibodies [9].”
BackgroundAlAufi, N. S., Chan, Y. M., Waly, M. I., Chin, Y. S., Yusof, B. N. M., & Ahmad, N. (2022) · Nutrients · doi:10.3390/nu14132777 · Cited by 58
“The main physio-pathological process of T2DM is the state of sustained hyperglycaemia attributed to pancreatic β-cells impaired insulin secretion or/and cell insulin resistance [60].”
BackgroundXu, F., Earp, J. E., Adami, A., Weidauer, L. A., & Greene, G. W. (2022) · Nutrients · doi:10.3390/nu14163324 · Cited by 60
“, 600 or more MET-minutes/week) is that the activity helps improves insulin sensitivity in skeletal muscles [32] and overall mitochondrial function [33].”
Chen, W., Li, X., Cheng, H., & Xia, W. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.10.008 · Cited by 50
Sphingolipid metabolism in brain insulin resistance and neurological diseases
Mei, M., Liu, M., Mei, Y., Zhao, J., & Li, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1243132 · Cited by 54
“Correspondingly, type 2 diabetes (T2 DM) accounts for about 90% of all diabetes cases and is mainly characterized by insulin resistance (62, 63).”
BackgroundPotential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arabshomali, A., Bazzazzadehgan, S., Mahdi, F., & Shariat‐Madar, Z. (2023) · Molecules · doi:10.3390/molecules28207209 · Cited by 69
“Each of these major hallmarks of T2DM provokes molecular mechanisms that contribute to microvascular or macrovascular dysfunction physiologic cell metabolism [29–32], which affects the metabolism of other cell types, contributing to the pathogenesis of diabetes.”
BackgroundZolkepli, H., Widodo, R. T., Mahmood, S., Salim, N., Awang, K., Ahmad, N., & Othman, R. (2022) · Polymers · doi:10.3390/polym14152991 · Cited by 65
“Type 2 diabetes is a widespread metabolic disorder that results from various factors, including defective insulin secretion, the insulin resistance of insulin-sensitive tissues, ageing and environmental factors, such as stress and obesity [6,7].”
Kopp, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1037750 · Cited by 67
Kaur, M., Misra, S., Swarnkar, P., Patel, P., Kurmi, B. D., Gupta, G. D., & Singh, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115723 · Cited by 64
Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases
Wieczorek, E., & Ożyhar, A. (2021) · Cells · doi:10.3390/cells10071768 · Cited by 59
MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake
Liu, R., Liu, C., He, X., Sun, P., Zhang, B., Yang, H., Shi, W., & Ruan, Q. (2022) · Nature Communications · doi:10.1038/s41467-022-31317-0 · Cited by 58
Regulation of Pdx1 by oxidative stress and Nrf2 in pancreatic beta-cells
Baumel-Alterzon, S., & Scott, D. K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1011187 · Cited by 61
“Diabetes is linked to various cellular stresses that generate ROS, such as hyperglycemia, hyperlipidemia, hypoxia, inflammation, and ER stress (8, 9) (Figure 1).”
BackgroundChen, Z., & Wen, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.973655 · Cited by 57
“The two major underlying mechanisms in the pathogenesis of T2DM are insulin resistance and deficient insulin secretion (3).”
BackgroundInfluentialObstructive Sleep Apnea, Circadian Clock Disruption, and Metabolic Consequences
Malicki, M., Karuga, F. F., Szmyd, B. M., Sochal, M., & Gabryelska, A. (2022) · Metabolites · doi:10.3390/metabo13010060 · Cited by 57
Moridpour, A. H., Kavyani, Z., Khosravi, S., Farmani, E., Daneshvar, M., Musazadeh, V., & Faghfouri, A. H. (2023) · Phytotherapy Research · doi:10.1002/ptr.8026 · Cited by 62
A review of type 2 diabetes mellitus and cognitive impairment
Kan, W., Qu, M., Wang, Y., Zhang, X., & Xu, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1624472 · Cited by 60
Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
Liu, J., Lang, G.-P., & Shi, J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291932 · Cited by 55
Winther, J. B., & Holst, J. J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15693 · Cited by 47
Narváez, J. J. U., & Campos, M. R. S. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15939 · Cited by 65
Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review
Khanna, M., Challa, S., Kabeil, A. S., Inyang, B., Gondal, F. J., Abah, G. A., Dhandapani, M. M., Manne, M., & Mohammed, L. (2021) · Cureus · doi:10.7759/cureus.18827 · Cited by 51
“It helps in regulating blood sugar in the body by increasing the uptake of glucose by various cells [1,2].”
BackgroundInfluentialLi, W., Li, L., Yang, F., Hu, Q., & Xiong, D. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3967 · Cited by 53
Liu, C., Cao, G., Li, J., Lian, S., Zhao, K., Zhong, Y., Xu, J., Chen, Y., Bai, J., Feng, H., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.107741 · Cited by 53
Chen, S., Yan, S., Aiheti, N., Kuribanjiang, K., Yao, X., Wang, Q., Zhou, T., & Yang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1109800 · Cited by 49
“T2DM is often associated with insulin resistance, increased inflammation, accumulation of advanced glycation end products, and elevated oxidative stress (36).”
BackgroundGhosh, N., Chacko, L., Bhattacharya, H., Vallamkondu, J., Nag, S., Dey, A., Karmakar, T., Reddy, P. H., Kandimalla, R. J. L., & Dewanjee, S. (2023) · Biomedicines · doi:10.3390/biomedicines11041126 · Cited by 55
Polycystic ovary syndrome and its management: In view of oxidative stress
Bhattacharya, K., Dey, R., Sen, D., Paul, N., Basak, A. K., Purkait, M. P., Shukla, N., Chaudhuri, G. R., Bhattacharya, A., Maiti, R., et al. (2024) · BioMolecular Concepts · doi:10.1515/bmc-2022-0038 · Cited by 65
“OS is known to play a crucial role in the pathogenesis of IR, even though the precise mechanism by which OS induces IR is not fully understood [106,107].”
BackgroundObesity- and lipid-related indices as a predictor of type 2 diabetes in a national cohort study
Wang, Y., Zhang, X., Li, Y., Gui, J., Mei, Y., Yang, X., Liu, H., Guo, L., Li, J., Lei, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1331739 · Cited by 58
“As far as we know, insulin resistance (IR) and islet b -cell dysfunction are the main pathophysiology of T2DM (46 – 48).”
BackgroundDiabetes and the associated complications: The role of antioxidants in diabetes therapy and care
Dilworth, L., Stennett, D., Facey, A., Omoruyi, F. O., Mohansingh, S., & Omoruyi, F. O. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117641 · Cited by 76
Mitochondrial Dysfunction in Diabetes: Shedding Light on a Widespread Oversight
Iheagwam, F. N., Joseph, A. J., Adedoyin, E. D., Iheagwam, O. T., & Ejoh, A. S. (2025) · Pathophysiology · doi:10.3390/pathophysiology32010009 · Cited by 63
“…from ATP synthesis, leading to increased energy dissipation and reduced ATP production [34]. mutations and cellular malfunction, respectively [36] ROS-mediated oxidative stress activates stress kinases and inflammatory pathways, further exacerbating dysfunction and Excessive nutrient intake,…”
Bioactive Compounds from Cardoon as Health Promoters in Metabolic Disorders
Silva, L. R., Jacinto, T. A., & Coutinho, P. (2022) · Foods · doi:10.3390/foods11030336 · Cited by 48
Wu, S., Jia, W., He, H., Yin, J., Xu, H., He, C., Zhang, Q., Peng, Y., & Cheng, R. (2023) · Nutrients · doi:10.3390/nu15214569 · Cited by 49
Xue, D., Narisu, N., Taylor, D. L., Zhang, M., Grenko, C. M., Taylor, H. J., Yan, T., Tang, X., Sinha, N., Zhu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.09.013 · Cited by 53
Natural products targeting inflammation-related metabolic disorders: A comprehensive review
Nainu, F., Frediansyah, A., Mamada, S. S., Permana, A. D., Salampe, M., Chandran, D., Emran, T. B., & Simal‐Gándara, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16919 · Cited by 57
“Finally, the genetic aspects also play a role in the pathophysiology of T2DM.”
BackgroundInfluentialPeres, M., Costa, H. S., Silva, M. A., & Albuquerque, T. G. (2023) · Nutrients · doi:10.3390/nu15245060 · Cited by 68
“Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by a state of hyperglycemia, which derives from impaired insulin secretion by pancreatic islet β -cells and insulin resistance [1].”
BackgroundA framework towards digital twins for type 2 diabetes
Zhang, Y., Qin, G., Aguilar, B. H., Rappaport, N., Yurkovich, J. T., Pflieger, L. T., Huang, S., Hood, L., & Shmulevich, I. (2024) · Frontiers in Digital Health · doi:10.3389/fdgth.2024.1336050 · Cited by 56
Potential of postbiotics for the treatment of metabolic disorders
Mishra, N., Garg, A., Ashique, S., & Bhatt, S. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103921 · Cited by 50
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Elahi, R., Nazari, M., Mohammadi, V., Esmaeilzadeh, K., & Esmaeilzadeh, A. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.009 · Cited by 53
Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments
Yu, X., He, H., Wen, J., Xu, X., Ruan, Z., Hu, R., Wang, F., & Ju, H. (2025) · Open Medicine · doi:10.1515/med-2024-1091 · Cited by 64
Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications
Li, M., Ding, L., Cao, L., Zhang, Z., Li, X., Li, Z., Xia, Q., Yin, K., Song, S., Wang, Z., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1534634 · Cited by 80
Therapeutic Potential of Seaweed-Derived Bioactive Compounds for Cardiovascular Disease Treatment
Cho, C. H., Lu, Y., Kim, M., Jeon, Y., & Lee, S. (2022) · Applied Sciences · doi:10.3390/app12031025 · Cited by 50
Azmiardi, A., Murti, B., Febrinasari, R. P., & Tamtomo, D. G. (2022) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.21.490 · Cited by 57
Tang, Y., Gao, Y., Nie, K., Wang, H., Shen, C., Su, H., Huang, W., & Dong, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117829 · Cited by 54
Retinal microcirculation: A window into systemic circulation and metabolic disease
Yuan, Y., Dong, M., Wen, S., Yuan, X., & Zhou, L. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109885 · Cited by 54
Ahmadieh-Yazdi, A., Karimi, M., Afkhami, E., Hajizadeh-Tafti, F., Kuchakzadeh, F., Yang, P., & Sheykhhasan, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116399 · Cited by 52
The effects of GLP‐1RA on inflammatory skin diseases: A comprehensive review
Paschou, I. A., Sali, E., Paschou, S. Α., Ψαλτοπούλου, Θ., Nicolaidou, E., & Stratigos, A. J. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20694 · Cited by 56
Dual role of macrophages in skeletal muscle atrophy: Mechanisms and therapeutic strategies
Shang, T., Hong-yi, X., Yao, X., Zhao, Z., Niu, X., Shen, Y., Chen, B., & Sun, H. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117589 · Cited by 53
Herath, R. P., Siriwardana, S. R., Ekanayake, C. D., Abeysekara, V., Kodithuwakku, S. U. A., & Herath, H. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215326 · Cited by 49
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Sebastián-Martín, A., Sánchez, B. G., Mora-Rodríguez, J. M., Bort, A., & Díaz‐Laviada, I. (2022) · Biomedicines · doi:10.3390/biomedicines10082026 · Cited by 52
“Inadequate compensatory insulin secretory responses are also associated with this process [92].”
BackgroundProgramming by maternal obesity: a pathway to poor cardiometabolic health in the offspring
Inzani, I., & Ozanne, S. E. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122001914 · Cited by 50
Jayachandran, M., Sunil, C., Zheng, X., & Xu, B. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134336 · Cited by 52
Psidium guajava L.: A Systematic Review of the Multifaceted Health Benefits and Economic Importance
Takeda, L. N., Laurindo, L. F., Guiguer, É. L., Bishayee, A., Araújo, A. C., Úbeda, L. C. C., Goulart, R. D. Á., & Barbalho, S. M. (2022) · Food Reviews International · doi:10.1080/87559129.2021.2023819 · Cited by 54
Chen, H. L., Wu, C.-W. G., Cao, L., Wang, R., Zhang, T. Y., & He, Z. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01637-x · Cited by 61
“This leads to a compensatory increase in insulin secretion, ultimately causing pancreatic β-cell damage and failure [9, 10].”
BackgroundZhang, W., Ren, H., Chen, W., Hu, B., Feng, C., Li, P., Shi, Y., & Fang, J. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02672-w · Cited by 58
Younis, I. Y., Khattab, A. R., Selim, N. M., Sobeh, M., El‐Hawary, S. S., & Bishbishy, M. H. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-08479-4 · Cited by 42
Zhang, L., Liu, Y., Xinzhou, W., & Zhang, X. (2023) · Nutrients · doi:10.3390/nu15061539 · Cited by 54
Nabil-Adam, A., Ashour, M. L., Tamer, T. M., Shreadah, M. A., & Hassan, M. A. (2023) · Catalysts · doi:10.3390/catal13020443 · Cited by 45
Trends in bimetallic nanomaterials and methods for fourth-generation glucose sensors
Naikoo, G. A., Arshad, F., Hassan, I. U., Omar, F. B., Tambuwala, M. M., Mustaqeem, M., & Saleh, T. A. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117042 · Cited by 41
Mgwenya, T. N., Abrahamse, H., & Houreld, N. N. (2024) · Wound Repair and Regeneration · doi:10.1111/wrr.13239 · Cited by 48
Liu, R., Zhang, F., He, X., & Huang, K. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c12480 · Cited by 51
Cabrera, O., FICORILLI, J. V., Shaw, J., Echeverri, F., Schwede, F., Chepurny, O. G., Leech, C. A., & Holz, G. G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101484 · Cited by 45
The many faces of diabetes. Is there a need for re-classification? A narrative review
Sakran, N., Graham, Y. N. H., Pintar, T., Yang, W., Kassir, R., Willigendael, E. M., Singhal, R., Kooreman, Z. E., Ramnarain, D., Mahawar, K. K., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00927-y · Cited by 55
“In a later stage, unsustainable serum glucose levels can lead to diabetic complications [15].”
BackgroundZong, P., Lin, Q., Feng, J., & Yue, L. (2022) · Cells · doi:10.3390/cells11030491 · Cited by 43
Luo, M.-J., Wang, Y., Chen, S., & Yang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.916603 · Cited by 43
Satheesan, A., Kumar, J. S., Leela, K. V., Murugesan, R., Chaithanya, V., & Angelin, M. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01556-2 · Cited by 48
Techno-Functional Properties and Applications of Inulin in Food Systems
Canazza, E., Grauso, M., Mihaylova, D. S., & Lante, A. (2025) · Gels · doi:10.3390/gels11100829 · Cited by 53
“More than 90% of cases are type 2 diabetes mellitus (T2DM), associated with impaired insulin secretion, reduced tissue sensitivity to insulin, and insufficient compensatory insulin release [284–286].”
Kreouzi, M., Theodorakis, N., Nikolaou, M., Feretzakis, G., Αναστασίου, Α., Kalodanis, K., & Sakagianni, A. (2025) · Microorganisms · doi:10.3390/microorganisms13010161 · Cited by 49
Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases
Moraes, K. C. M., & Montagne, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.728407 · Cited by 49
Deenadayalan, A., Subramanian, V., Paramasivan, V., Veeraraghavan, V. P., Rengasamy, G., Janaki, C. S., Rajagopal, P., & Jayaraman, S. (2021) · Molecules · doi:10.3390/molecules26247689 · Cited by 48
“Skeletal muscles that are insulin resistant do not respond to insulin, which causes impairment in the insulin signaling pathway and, as a result, a reduction in GLUT 4 levels and GU by these cells [34].”
BackgroundNarváez, J. J. U., & Campos, M. R. S. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14268 · Cited by 53
Deledda, A., Palmas, V., Heidrich, V., Fosci, M., Lombardo, M., Cambarau, G., Lai, A., Melis, M., Loi, E., Loviselli, A., et al. (2022) · Metabolites · doi:10.3390/metabo12111092 · Cited by 55
“Among the environmental factors, an incorrect and unhealthy lifestyle (sedentary behavior, high-caloric, and poor eating habits), the consequent condition of overweight or obesity [6], and especially the related deficit of metabolically active lean mass play a key role.”
BackgroundZhang, L., Xinzhou, W., & Zhang, X. (2022) · Foods · doi:10.3390/foods11192961 · Cited by 40
Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators
Ramatchandirin, B., Pearah, A., & He, L. (2023) · Life · doi:10.3390/life13020515 · Cited by 47
Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases
Kurakula, H., Vaishnavi, S., Sharif, M. Y., & Ellipilli, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c01703 · Cited by 41
Susilawati, E., Levita, J., Susilawati, Y., & Sumiwi, S. A. (2023) · Medical Sciences · doi:10.3390/medsci11030050 · Cited by 38
“More than 90% of DM cases are type 2 (T2DM), which is mainly caused by a combination of two factors: the failure of insulin secretion by the pancreatic β-cells and the inability of insulin-sensitive tissues to respond to insulin (insulin resistance) [3,5].”
BackgroundThe vascular complications of diabetes: a review of their management, pathogenesis, and prevention
Meir, J., Huang, L., Mahmood, S., Whiteson, H. Z., Cohen, S., & Aronow, W. S. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2279533 · Cited by 48
“Studies like UKPDS [86] and the Diabetes Control and Complications Trial (DCCT) [88] found intensive glycemic control, especially in younger patients, leads to better cardiovascular outcomes, emphasizing the importance of glycemic control as an intervention target.”
BackgroundMethodAmylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
Eržen, S., Tonin, G., Jurišić‐Eržen, D., & Klen, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031517 · Cited by 49
“In T2DM, several environmental and genetic factors contribute to impaired insulin production by pancreatic β -cells and impaired insulin sensitivity in tissues with consequent clinical manifestation of hyperglycemia [4].”
BackgroundNemati, M., Azarbayjani, A. F., Al‐Salami, H., Asl, E. R., & Rasmi, Y. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3732 · Cited by 39
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.